U
CL icon

UBS’s Colgate-Palmolive CL Stock Holding History

UBS’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.12M Buy
47,900
+44,100
+1,161% +$2.91M ﹤0.01% 2482
2014
Q2 		$259K Sell
3,800
-100
-3% -$6.7K ﹤0.01% 4886
2014
Q1 		$253K Sell
3,900
-11,300
-74% -$712K ﹤0.01% 4948
2013
Q4 		$991K Buy
15,200
+3,600
+31% +$230K ﹤0.01% 3557
2013
Q3 		$688K Sell
11,600
-122,800
-91% -$7.28M ﹤0.01% 3765
2013
Q2 		$7.7M Buy
+134,400
New +$7.98M 0.01% 1242

Other funds holding CL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

UBS's CL Position: Q3 2014 in Review

UBS increased its Colgate-Palmolive (CL) stake by 12% in Q3 2014, buying an estimated $51.3M and bringing the position to 7,358,569 shares worth $480M. The position accounts for 0.35% of the portfolio, ranked #44.

UBS first reported a position in CL in Q2 2013 and has held it in 6 quarters since. 1,189 funds tracked by Wall St. Rank hold CL as of Q3 2014.

  • UBS held 7,358,569 shares of Colgate-Palmolive worth $480M as of Q3 2014.
  • UBS bought 777,282 Colgate-Palmolive shares in Q3 2014, an estimated $51.3M.
  • Colgate-Palmolive made up 0.35% of UBS's portfolio in Q3 2014, its #44 holding.
  • UBS first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 6 quarters since.
  • 1,189 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.